Visible Genetics' HIV resistance testing software:
This article was originally published in Clinica
Executive Summary
Visible Genetics has received US FDA 510(k) clearance to market its next-generation HIV resistance interpretation software for use with its TRUGENE HIV-1 genotyping test. The GuideLines 5.0 Rules software includes the latest data on HIV drug resistance, including information on the newly launched HIV drugs, tenofovir and lopinavir/ritonavir. The HIV virus is constantly evolving and it is critical that HIV resistance testing is conducted using technology that is both fully validated and up-to-date, says the Toronto, Canada firm.